Fortress Biotech

United States
Troy, New Hampshire, United States, 10014

Company profile

Fortress Biotech company profile

Fortress Biotech is a biopharmaceutical company focusing on acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and partners it founded and holds significant minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.

Business identity

Contact email
[email protected]
Phone number
212-574-2800
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$50,000+
Founded
2006-01-01, Year

Headquarters

Postal code
10014
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
14
Total equity funding
$122.1M
Last funding
Post IPO Equity / $8M / 2024-09-20
Last equity funding
Post IPO Equity / $8M
Investors
3
Lead investors
3
Founders
1
Articles
143
Exited on
2011-12-30

Founders and investors

Founders

Lindsay Rosenwald

Lead investors

Hercules CapitalNational Securities CorporationOaktree Capital Management

Investors

Hercules CapitalNational Securities CorporationOaktree Capital Management